|
WO2020252145A1
|
|
Neoantigen immunotherapies
|
|
WO2019217655A1
|
|
Immune repertoire patterns
|
|
US2019070255A1
|
|
Epitope mimics
|
|
US2019031722A1
|
|
Interventions for flavivirus infections
|
|
WO2016007870A2
|
|
Immune recognition motifs
|
|
US2018221474A1
|
|
Immunoglobulin polypeptide fractions from products of domestic animals
|
|
WO2014200910A2
|
|
Bioinformatic processes for determination of peptide binding
|
|
EP3008204A2
|
|
Mathematical processes for determination of peptidase cleavage
|
|
WO2014078373A1
|
|
Antimicrobial compositions
|
|
US2013230516A1
|
|
Targeted cryptosporidium biocides
|
|
EP2771349A2
|
|
Bioinformatic processes for determination of peptide binding
|
|
WO2011119484A1
|
|
Bioinformatic processes for determination of peptide binding
|
|
WO2007047189A2
|
|
Targeted biocides
|
|
US2006147442A1
|
|
Biocides
|
|
AU2005332655A1
|
|
Biocides
|
|
US2005014932A1
|
|
Targeted biocides
|
|
US2004253581A1
|
|
Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins
|
|
AU8484301A
|
|
Fatty liver disease resistant bovines
|
